Skip to content

The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness

The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05098743
Enrollment
65
Registered
2021-10-28
Start date
2021-11-19
Completion date
2022-09-01
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence, Self Efficacy

Keywords

Medication Knowledge, Medication Social Support, Medication Self Efficacy, Mobile Phone Applications, Medically Underserved Populations

Brief summary

Medication adherence is a critical aspect of achieving optimal health outcomes. Thirty to 50% of patients adhere to long-term medication treatment of chronic diseases. Non adherence has been shown to result in worsening disease, increased healthcare expenditures, complications and even death. Medically underserved communities have higher rates of medication nonadherence and a higher prevalence of chronic conditions and often receive care at Federally Qualified Health Centers (FQHCs) which are reporting caring for increasingly complex chronic conditions. Smartphone mobile phone ownership has increased to 76% in low income Americans, but this population has been underrepresented in mobile health intervention studies. This two-group, cluster randomized by site, randomized controlled trial will investigate the effect of a medication adherence smartphone mobile application (app) which provides reminders on patient medication adherence, on medication self-efficacy, medication knowledge and medication social support. Independently, each of these concepts have been shown to support medication adherence. However in the context of delivery by a medication adherence app in a variety of chronic illnesses in a medically underserved population, little is known. It will also explore if those who accessed educational materials within the app report greater medication knowledge than those who do not and if participants who choose to use the additional Medfriend feature report greater medication social support than those who do not. The study will also explore patients' perceptions on the usefulness and satisfaction with the app features.

Detailed description

Medication adherence is a critical aspect of achieving optimal health outcomes. Thirty to 50% of patients adhere to long-term medication treatment of chronic diseases. Non adherence has been shown to result in worsening disease, increased healthcare expenditures, complications and even death. Medically underserved communities have higher rates of medication nonadherence and a higher prevalence of chronic conditions and often receive care at Federally Qualified Health Centers (FQHCs) which are reporting caring for increasingly complex chronic conditions. Smartphone mobile phone ownership has increased to 76% in low income Americans, but this population has been underrepresented in mobile health intervention studies. This two-group, cluster randomized by site, randomized controlled trial will investigate the effect of a medication adherence smartphone mobile application (app) which provides reminders on patient medication adherence, on medication self-efficacy, medication knowledge and medication social support. Independently, each of these concepts have been shown to support medication adherence. However in the context of delivery by a medication adherence app in a variety of chronic illnesses in a medically underserved population, little is known. It will also explore if those who accessed educational materials within the app report greater medication knowledge than those who do not and if participants who choose to use the additional Medfriend feature report greater medication social support than those who do not. The study will also explore patients' perceptions on the usefulness and satisfaction with the app features.

Interventions

BEHAVIORALMedisafe smartphone mobile application

The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.

Patients will receive a printed out medication list from their electronic medical record.

Sponsors

Vanderbilt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults aged 18 years and older * speak and understand English * personally own and use an Android or Apple smartphone and * take at least 1 medication for a chronic illness based on their computerized medical record at the health center.

Exclusion criteria

* already using a medication reminder app or other electronic reminder system such as phone alarms * own smartphones that are not capable of downloading the app * patients with severe dementia or serious mental illness, and * inability to use a mobile phone or the medication reminder software either physically or cognitively.

Design outcomes

Primary

MeasureTime frameDescription
Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS)Baseline to 30 days.The ARMS is a global (continuous) 12-item scale, responses range from 1 (none) to 4 (all of the time) with a possible score of 12-48, patients with low ARMS scores indicate better adherence, it is valid and reliable in a low-literacy chronic disease population.
Change in Medication Self-efficacy as Measured by the Self-efficacy for Appropriate Medication Use Scale (SEAMS)Baseline to 30 days.The SEAMS is a global (continuous) 13-item scale, responses range from 1 (not confident) to 3 (very confident), with a possible score of 13-39. Patients with higher scores indicate higher levels of self-efficacy for medication adherence. It is valid and reliable in low-literacy chronic disease populations. Patients are asked their level of confidence about taking medications correctly.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from a healthcare center, as noted in the protocol section.

Participants by arm

ArmCount
Participants Using the Medication Adherence Mobile Application.
Participants in this arm will use the Medisafe app to receive medication reminders for thirty days. Medisafe smartphone mobile application: The medication adherence smartphone mobile application (app) will provide reminders to take individual patient medications and offers medication information and a social support feature.
30
Participants Using a Printed Copy of Their Medication List.
Participants in this arm will use a printed out copy of their medication list for thirty days. Printed medication list: Patients will receive a printed out medication list from their electronic medical record.
31
Total61

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up12
Overall StudyOne participant had no data because they were unable to download the app despite multiple attempts10

Baseline characteristics

CharacteristicParticipants Using the Medication Adherence Mobile Application.Participants Using a Printed Copy of Their Medication List.Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants6 Participants9 Participants
Age, Categorical
Between 18 and 65 years
27 Participants25 Participants52 Participants
Age, Continuous53.50 years51 years53 years
ARMS18.5 units on a scale17.0 units on a scale18.0 units on a scale
Race/Ethnicity, Customized
Asian
5 participants2 participants7 participants
Race/Ethnicity, Customized
Black or African American
10 participants13 participants23 participants
Race/Ethnicity, Customized
Chose not to respond
1 participants1 participants2 participants
Race/Ethnicity, Customized
Hispanic/Latino
4 participants10 participants14 participants
Race/Ethnicity, Customized
Native American or Alaska Native
1 participants0 participants1 participants
Race/Ethnicity, Customized
Other
3 participants2 participants5 participants
Race/Ethnicity, Customized
White
6 participants3 participants9 participants
Region of Enrollment
United States
30 Participants31 Participants61 Participants
SEAMS29.0 units on a scale31.0 units on a scale29.0 units on a scale
Sex: Female, Male
Female
17 Participants12 Participants29 Participants
Sex: Female, Male
Male
13 Participants19 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 31
other
Total, other adverse events
0 / 300 / 31
serious
Total, serious adverse events
0 / 300 / 31

Outcome results

Primary

Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS)

The ARMS is a global (continuous) 12-item scale, responses range from 1 (none) to 4 (all of the time) with a possible score of 12-48, patients with low ARMS scores indicate better adherence, it is valid and reliable in a low-literacy chronic disease population.

Time frame: Baseline to 30 days.

ArmMeasureValue (MEDIAN)
Participants Using the Medication Adherence Mobile Application.Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS)-4.0 score on a scale
Participants Using a Printed Copy of Their Medication List.Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS)-1.0 score on a scale
Primary

Change in Medication Self-efficacy as Measured by the Self-efficacy for Appropriate Medication Use Scale (SEAMS)

The SEAMS is a global (continuous) 13-item scale, responses range from 1 (not confident) to 3 (very confident), with a possible score of 13-39. Patients with higher scores indicate higher levels of self-efficacy for medication adherence. It is valid and reliable in low-literacy chronic disease populations. Patients are asked their level of confidence about taking medications correctly.

Time frame: Baseline to 30 days.

ArmMeasureValue (MEDIAN)
Participants Using the Medication Adherence Mobile Application.Change in Medication Self-efficacy as Measured by the Self-efficacy for Appropriate Medication Use Scale (SEAMS)3.5 score on a scale
Participants Using a Printed Copy of Their Medication List.Change in Medication Self-efficacy as Measured by the Self-efficacy for Appropriate Medication Use Scale (SEAMS)0.0 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026